Prevalence of hyposalivation and associated factors in survivors of head and neck cancer treated with radiotherapy
Conclusion: Hyposalivation is a highly prevalence late-onset side effect of radiotherapy in patients treated for head and neck cancer, with a greater chance of occurrence among those who received higher doses of radiation and those who ended therapy less than 22 months before our study . Concomitant chemotherapy and radiotherapy does not seem to increase the chances of hyposalivation compared to radiotherapy alone.
Source: Journal of Applied Oral Science - Category: Dentistry Source Type: research
More News: Brazil Health | Cancer | Cancer & Oncology | Carcinoma | Chemotherapy | Dentistry | Head and Neck Cancer | Hypopharyngeal Cancer | Laryngeal Cancer | Oral Cancer | Oral Cavity Cancer | Oropharyngeal Cancer | Science | Skin Cancer | Squamous Cell Carcinoma | Study | Xerostomia